Details for New Drug Application (NDA): 081295
✉ Email this page to a colleague
NDA 081295 describes ESTRACE, which is a drug marketed by Allergan and Bristol Myers Squibb and is included in four NDAs. It is available from three suppliers. Additional details are available on the ESTRACE profile page.
The generic ingredient in ESTRACE is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
The generic ingredient in ESTRACE is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 081295
| Tradename: | ESTRACE |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | estradiol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 081295
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Jun 30, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
